These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 24559319)
1. MB109 as bioactive human bone morphogenetic protein-9 refolded and purified from E. coli inclusion bodies. Kuo MM; Nguyen PH; Jeon YH; Kim S; Yoon SM; Choe S Microb Cell Fact; 2014 Feb; 13(1):29. PubMed ID: 24559319 [TBL] [Abstract][Full Text] [Related]
2. Optimized procedure for renaturation of recombinant human bone morphogenetic protein-2 at high protein concentration. Vallejo LF; Rinas U Biotechnol Bioeng; 2004 Mar; 85(6):601-9. PubMed ID: 14966801 [TBL] [Abstract][Full Text] [Related]
3. Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent. Upadhyay V; Singh A; Jha D; Singh A; Panda AK Microb Cell Fact; 2016 Jun; 15():100. PubMed ID: 27277580 [TBL] [Abstract][Full Text] [Related]
4. Expression, purification, and refolding of a recombinant human bone morphogenetic protein 2 in vitro. Zhang Y; Ma Y; Yang M; Min S; Yao J; Zhu L Protein Expr Purif; 2011 Feb; 75(2):155-60. PubMed ID: 20691269 [TBL] [Abstract][Full Text] [Related]
5. Solubilization and refolding of bacterial inclusion body proteins. Singh SM; Panda AK J Biosci Bioeng; 2005 Apr; 99(4):303-10. PubMed ID: 16233795 [TBL] [Abstract][Full Text] [Related]
6. Refolding and purification of cGMP-grade recombinant human neurturin from Escherichia coli inclusion bodies. Xi G; Esfandiary R; Sacramento CB; Jouihan H; Sharma A; Roth R; Linke T Protein Expr Purif; 2020 Apr; 168():105552. PubMed ID: 31866372 [TBL] [Abstract][Full Text] [Related]
7. Purification of recombinant ovalbumin from inclusion bodies of Escherichia coli. Upadhyay V; Singh A; Panda AK Protein Expr Purif; 2016 Jan; 117():52-8. PubMed ID: 26390939 [TBL] [Abstract][Full Text] [Related]
8. Accurate quantitation for in vitro refolding of single domain antibody fragments expressed as inclusion bodies by referring the concomitant expression of a soluble form in the periplasms of Escherichia coli. Noguchi T; Nishida Y; Takizawa K; Cui Y; Tsutsumi K; Hamada T; Nishi Y J Immunol Methods; 2017 Mar; 442():1-11. PubMed ID: 27939301 [TBL] [Abstract][Full Text] [Related]
9. A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditions. Dechavanne V; Barrillat N; Borlat F; Hermant A; Magnenat L; Paquet M; Antonsson B; Chevalet L Protein Expr Purif; 2011 Feb; 75(2):192-203. PubMed ID: 20851186 [TBL] [Abstract][Full Text] [Related]
10. Refolding and purification of unprocessed porcine myostatin expressed in Escherichia coli. Jin HJ; Dunn MA; Borthakur D; Kim YS Protein Expr Purif; 2004 May; 35(1):1-10. PubMed ID: 15039059 [TBL] [Abstract][Full Text] [Related]
11. Expression, purification, and renaturation of bone morphogenetic protein-2 from Escherichia coli. Long S; Truong L; Bennett K; Phillips A; Wong-Staal F; Ma H Protein Expr Purif; 2006 Apr; 46(2):374-8. PubMed ID: 16298141 [TBL] [Abstract][Full Text] [Related]
12. Expression, purification, and refolding of biologically active Acinetobacter baumannii OmpA from Escherichia coli inclusion bodies. McConnell MJ; Pachón J Protein Expr Purif; 2011 May; 77(1):98-103. PubMed ID: 21130880 [TBL] [Abstract][Full Text] [Related]
13. Adsorptive refolding of a highly disulfide-bonded inclusion body protein using anion-exchange chromatography. Chen Y; Leong SS J Chromatogr A; 2009 Jun; 1216(24):4877-86. PubMed ID: 19419725 [TBL] [Abstract][Full Text] [Related]
14. Refolding and purification of recombinant human VEGF-121 expressed as inclusion bodies in Escherichia coli. Hu ZM; Ma L; Zhou MQ; Gao JM; Wang XN Nan Fang Yi Ke Da Xue Xue Bao; 2006 Aug; 26(8):1083-6. PubMed ID: 16939889 [TBL] [Abstract][Full Text] [Related]
15. Refolding and purification of recombinant human PDE7A expressed in Escherichia coli as inclusion bodies. Richter W; Hermsdorf T; Kronbach T; Dettmer D Protein Expr Purif; 2002 Jun; 25(1):138-48. PubMed ID: 12071709 [TBL] [Abstract][Full Text] [Related]
16. Optimization of inclusion body solubilization and renaturation of recombinant human growth hormone from Escherichia coli. Patra AK; Mukhopadhyay R; Mukhija R; Krishnan A; Garg LC; Panda AK Protein Expr Purif; 2000 Mar; 18(2):182-92. PubMed ID: 10686149 [TBL] [Abstract][Full Text] [Related]
17. Refolding and simultaneous purification by three-phase partitioning of recombinant proteins from inclusion bodies. Raghava S; Barua B; Singh PK; Das M; Madan L; Bhattacharyya S; Bajaj K; Gopal B; Varadarajan R; Gupta MN Protein Sci; 2008 Nov; 17(11):1987-97. PubMed ID: 18780821 [TBL] [Abstract][Full Text] [Related]
18. Efficient production of a correctly folded mouse α-defensin, cryptdin-4, by refolding during inclusion body solubilization. Tomisawa S; Sato Y; Kamiya M; Kumaki Y; Kikukawa T; Kawano K; Demura M; Nakamura K; Ayabe T; Aizawa T Protein Expr Purif; 2015 Aug; 112():21-8. PubMed ID: 25913370 [TBL] [Abstract][Full Text] [Related]
19. Refolding, Crystallization, and Crystal Structure Analysis of a Scavenger Receptor Cysteine-Rich Domain of Human Salivary Agglutinin Expressed in Escherichia coli. Zhang C; Lu P; Wei S; Hu C; Miyoshi M; Okamoto K; Itoh H; Okuda S; Suzuki M; Kawakami H; Nagata K Protein J; 2024 Apr; 43(2):283-297. PubMed ID: 38265733 [TBL] [Abstract][Full Text] [Related]
20. Refolding and purification of Zymomonas mobilis levansucrase produced as inclusion bodies in fed-batch culture of recombinant Escherichia coli. Sunitha K; Chung BH; Jang KH; Song KB; Kim CH; Rhee SK Protein Expr Purif; 2000 Apr; 18(3):388-93. PubMed ID: 10733894 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]